search icon

    Market Snapshot

    blog search icon

    Molecular Partners AG Stock Ratios, Return on Equity and Profit Margin

    Molecular Partners AG

    (NASDAQ:MOLN)

    $6.631

    0.18 (2.81%)

    At Close: 4:00 PM

    MOLN Financial

    Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

    Quick Ratio

    14.40

    Enterprise Value/Revenue

    -

    Fiscal Year Ends

    Dec

    Current Ratio

    14.40

    Peg Ratio (5 yr Expected)

    -

    Enterprise Value/EBITDA

    -

    Most Recent Quarter (MRQ)

    Sep. 2022

    Next Earning Date

    N/A

    Profit Margin

    -

    Revenue (TTM)

    188.71 Million

    Quarterly Revenue Growth (YOY)

    -31.40%

    Operating Margin (TTM)

    -

    Revenue Per Share (TTM)

    5.82

    SALES GROWTH PAST 5Y

    -

    Operating Margin

    (TTM)

    -

    Profit Margin

    -

    Revenue

    (TTM)

    188.7 Million

    Revenue Per Share

    (TTM)

    5.82

    Return & Ratios

    It is true that no indicator can be relied on to predict company health 100% of the time. However, a number of indicators can provide insight into trading trends. A number of ratios can measure a company's strength, both in comparison to its peers and to its past performance. A number of ratios can be used to measure the performance of an organization, such as the Return On Investment (ROI), Return On Assets (ROA) as well as Return On Equity (ROE).

    Gross Margin

    -

    Return on Investment (TTM)

    -56%

    Return on Equity (TTM)

    129.80%

    Gross Profit (TTM)

    -

    Return on Assets (TTM)

    108.30%

    Net Income AVI To Common (TTM)

    117 Million

    EBITDA

    116.6 Million

    DILUTED EPS (TTM)

    3.85

    Quarterly Earnings Growth (YOY)

    -7.40%

    Graph For Net Income

    Graph For EBITDA

    Cash & Equity Ratios

    Total Cash (MRQ)

    267.13 Million

    Total Debt (MRQ)

    5.15 Million

    Book Value Per Share (MRQ)

    3.85

    Levered Free Cash Flow (TTM)

    63.44 Million

    Total Cash Per Share (MRQ)

    3.85

    Total Debt/Equity (MRQ)

    0.02

    Operating Cash Flow (TTM)

    113.5 Million

    Total Cash

    Total Cash Per Share

    Book Value Per Share

    Operating Cash Flow

    Frequently Asked Questions

    icon

    When was the last time Molecular Partners AG (NASDAQ:MOLN) reported earnings?

    Molecular Partners AG (MOLN) published its most recent earnings results on undefined. NaN for the quarter ended Sep. 2022.

    icon

    What is Molecular Partners AG's current ROE?

    An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Molecular Partners AG (NASDAQ:MOLN)'s trailing twelve month ROE is 129.80%.

    icon

    What are ROA and ROI telling us?

    It is sometimes helpful for shareholders to know how their investments are doing. Return on investment (ROI) for Molecular Partners AG (MOLN) is -56%. As ROI percentages rise, profits exceed costs, thus analysts consider such investments to be a general win.  In contrast, the Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Molecular Partners AG (MOLN) currently has a ROA of 108.30% Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.

    icon

    Where did MOLN's net profit margin stand at?

    MOLN reported a profit margin of N/A in the last quarter ended Sep. 2022. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.

    icon

    When will Molecular Partners AG's next earnings report be released?

    Although Molecular Partners AG has not yet announced its next earnings date, it is expected to be, undefined. NaN, NaN based on last year's announcement date.

    icon

    What is MOLN's short-term liquidity position?

    According to Molecular Partners AG (MOLN)'s current performance indicators, the Quick Ratio of 14.40 in the last reported quarter. The current ratio of MOLN stands at 14.40 in the last reported quarterand a Debt/Eq ratio of 0.02.